Roth Capital Downgrades Inovio Pharmaceuticals (INO) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 0.60 -0.17 (22.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $11.69 | |||
| Open | $0.86 | 52 Week Low | $4.50 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-0.28 | |||
| Volume | 78,804,880 | |||||
